RHT — Resonance Health Share News
0.000.00%
Last trade - 00:00- AU$21.84m
- AU$23.20m
- AU$11.16m
Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
Brief: Resonance Health Says Martin Blake Retires As Chair
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$13.775 Mln
Brief: Resonance Seeks Trading Halt Pending Announcement On Execution Of Contract For Services For Clinical Trial By Pharma Co
Australia's Resonance Health jumps on over 3-fold rise in FY24 earnings
Brief: Resonance Health Announces Expansion Of Its Trialswest Business In Western Australia
Brief: Resonance Health Posts 1HFY24 Revenue Of A$3.26 Mln
Brief: Resonance Health Says acquisition of TrialsWest Group
Brief: Resonance Health Seeks Trading Halt
Brief: Resonance Health Says Benjamin Carruthers Appointed As CFO
Australia's Resonance Health jumps most in 1-1/2 years on drug trial deal
Brief: Resonance Health Contracted For Clinical Drug Trial Worth A$6.33 Million Over 18 Months
Brief: Resonance Health Seeks Trading Halt
Brief: Resonance Health Says Hepafatsmart Cleared By US FDA
Brief: Resonance Health Announces Appointment Of Andrew Harrison As CEO
Australia's Resonance Health jumps on contracts for clinical services
Brief: Resonance Health Says Contracted For Two New Clinical Trials
Australia's Resonance Health jumps most in 3 months on clinical service launch
Brief: Resonance Health Says Ferriscan Now Available On 3 Tesla (3T) Mri Scanning Machines